Navigation Links
Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
Date:4/15/2008

Novel Nucleoside-Sparing Regimen Designed to Avoid Risk of Toxicity

Associated with Nucleoside Class of HIV Drugs

KENILWORTH, N.J., April 15 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that it has initiated a Phase II clinical study with vicriviroc, its investigational CCR5 antagonist, for use in first-line therapy of adult treatment-naive HIV-infected patients with R5-type virus only. Vicriviroc is a next-generation HIV entry inhibitor designed to prevent the virus from infecting CD4 cells by blocking its predominant entry route, the CCR5 co-receptor. Approximately 80-90 percent of treatment-naive patients have virus that uses the CCR5 co-receptor.(1) Vicriviroc also is being studied in two large Phase III clinical studies in treatment-experienced HIV patients, which are ongoing and currently enrolling patients.

The study in treatment-naive patients evaluates the virologic benefit of vicriviroc, administered once-daily as a single 30 mg tablet, in combination with ritonavir-boosted atazanavir,(2) compared to a control group receiving Truvada (emtricitabine and tenofovir disoproxil fumarate)(3) plus ritonavir- boosted atazanavir, which is a currently recommended option for first-line therapy. Atazanavir is a product in the protease inhibitor (PI) class of HIV medications. Truvada is a combination product in the nucleoside reverse transcriptase inhibitor (NRTI) class.

"A nucleoside-sparing vicriviroc regimen for initial treatment may have the added strategic benefit of preserving most products used to create a highly active antiretroviral therapy "cocktail" for later use in patients, while also avoiding the risk of toxicity known to be associated with the nucleoside
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
2. Schering-Plough Reports Top-Line Results of the IDEAL Study
3. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
4. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
5. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
6. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
7. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
8. Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer
9. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
10. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
11. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... in the Deutsche Bank Health Care Conference to be ... Mr. Adrian Adams , Chief Executive ... of the Company and its product pipeline at 12:00 ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation ...
(Date:5/24/2013)... 24, 2013 The potential of ... delivery of therapeutic agents has been receiving undeniable attention ... showing significant promise. The crucial formulation considerations for orally ... play a major role in the efficiency of pulmonary ... development of new formulation techniques and devices in recent ...
(Date:5/23/2013)... May 23, 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... named the 2013 Life Science Firm of the Year by ... Vanda was honored at the TCM,s 25 th Annual ... Maryland.  The Tech Awards Celebration recognizes the leaders and innovators ... Maryland and the surrounding regions. ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... ... , ... - Will Use BrainTrack,s College Campus Data to Enhance Elsevier Evolve,Website Registrations ... technical and,medical information products and services, and BrainTrack,( http://www.braintrack.com ), the widely referenced ...
... 8 ARKRAY, Inc., a global leader of human ... announced an exclusive distribution agreement with scil animal care ... a global organization focused on providing high quality veterinary ... will be to re-introduce the SPOTCHEM(TM) EZ, a small ...
Cached Medicine Technology:Elsevier Selects BrainTrack Directory as Supplier of College Data 2Elsevier Selects BrainTrack Directory as Supplier of College Data 3Elsevier Selects BrainTrack Directory as Supplier of College Data 4ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer 2
(Date:5/24/2013)... 2013 The creative flair and design ... University (PolyU)'s Institute of Textiles and Clothing (ITC) have ... Fashion Show held on 22 May at The Mira ... of ITC design students, various knitwear producers and yarn ... collections of four outfits from 20 graduating students majoring ...
(Date:5/24/2013)... 23 (HealthDay News) -- Certain statins -- the ... chances of developing type 2 diabetes, a new ... patients taking atorvastatin (brand name Lipitor), rosuvastatin (Crestor) ... Focusing on almost 500,000 Ontario residents, researchers in ... diabetes were low in patients prescribed statins. Still, ...
(Date:5/24/2013)... National Geographic questioned in an article on ... is getting lost in the swirl of summer kickoff. ... some research and analysis on the subject based on publicly ... evaluation of around 180 ecards shared by Americans, suggests that ... of fun and celebration. In the modern era of ...
(Date:5/24/2013)... Texas (PRWEB) May 24, 2013 This ... 2022” provides an overview of the risk factors and ... (8MM) (US, France, Germany, Italy, Spain, UK, Australia, and ... cases of meningococcal disease segmented by age (<1, 1–4, ... (B, C, Y, and W-135) in these markets. The ...
(Date:5/24/2013)... May 24, 2013 Just about any bodyweight ... Mike Whitfield, a trainer based in Dallas, GA that uses ... there’s one pushup that is not used enough. , “The ... make the standard pushup more challenging. By keeping your hands ... and the abs are being worked much harder than a ...
Breaking Medicine News(10 mins):Health News:PolyU Stages Knitwear Fashion Show 2Health News:Could Statins Raise Diabetes Risk? 2Health News:Could Statins Raise Diabetes Risk? 3Health News:Is Memorial Day More Than A Three-Day Weekend 2Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 2Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 3Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 4Health News:Medicine Ball Pushups, a Unique Bodyweight Chest Exercise, Released in Video from BodyweightTorch.com 2
... By Kathleen Doheny HealthDay Reporter , TUESDAY, June ... levels does not reduce the odds of cardiovascular disease for ... of heart problems, as researchers have known. But it may ... , , Strict control of blood sugar in a certain ...
... ... Medical Design and Manufacturing Exposition in New York City, MDEA winning products were celebrated in ... Hand Hygiene System was named a gold award winner in the category of general hospital ... ...
... Conducting a ... time and money, and reduce post-implementation problems. Let PBG take the worries out of ... ... -- Once a hardware or software system is installed, it must be properly maintained to ...
... decreased drastically over the last few decades, we still have ... President, J. Fred Ralston, Jr., MD, FACP, said as a ... Control and Prevention, ACP called for a comprehensive federal strategy ... taken by states currently. "A comprehensive tobacco control and ...
... had lower rates of mammography screening than middle-class women, ... "Health insurance is a necessary condition for ... said Nasar Ahmed, Ph.D., chair of epidemiology and biostatistics ... Social Work at Florida International University. Ahmed was ...
... bans in two large Minnesota cities was not associated with ... to higher employment in restaurants, according to new research. ... of clean indoor air policies on bars and restaurants as ... published studies of the economic impact of smoking bans, this ...
Cached Medicine News:Health News:Tight Blood Sugar Control in Older Diabetics May Not Reduce Heart Risk 2Health News:Tight Blood Sugar Control in Older Diabetics May Not Reduce Heart Risk 3Health News:Xhale Innovation's HyGreen Hand Hygiene System Brings Home the Gold 2Health News:PBG Offers a Pre-Upgrade Site Survey for Ericom, VMware, and NetApp Upgrades 2Health News:Internists outline comprehensive federal strategy to control tobacco use 2Health News:Counseling increased mammography use among low-income women with health insurance 2Health News:Bars, restaurants see no significant employment change under smoking bans in 2 cities 2Health News:Bars, restaurants see no significant employment change under smoking bans in 2 cities 3Health News:Bars, restaurants see no significant employment change under smoking bans in 2 cities 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: